Last reviewed · How we verify

NCT05108948: COFTASD

Research of Factors Determining the Improvement of Quality of Life at One Year of Adult Patients Treated for Spinal Deformity (COFTASD)

Recruiting now Last updated 29 February 2024
What this trial tests

trial testing Quality of life questionnaires in Spinal Deformity in 866 participants. Currently enrolling.

Timeline
23 October 2021
Primary endpoint
23 October 2031
23 October 2041

Quick facts

Lead sponsorElsan
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment866
Start date23 October 2021
Primary completion23 October 2031
Estimated completion23 October 2041
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Elsan — full company profile →

Who can join

18 and older, any sex, with Spinal Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to find the predictive factors of improvement of the quality of life of operated patients from spinal deformity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Quality of life questionnaires

Trials testing the same drug.

Other recruiting trials for Spinal Deformity

Currently open trials in the same condition.

Other Elsan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05108948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing